Cargando…
Use of sotrovimab in vaccinated versus unvaccinated COVID‐19 patients in a resource‐limited emergency department during the omicron surge
OBJECTIVE: The treatment of outpatient COVID‐19 patients at high risk of disease progression has been challenging, as both the virus and available therapeutics change. Here, we sought to evaluate the effect of vaccination status on the use of sotrovimab during the early phase of the Omicron surge. M...
Autores principales: | Nene, Rahul V., Santodomingo, Melodie A., Balog, Bruce, Martinez, Hector, Murillo, Elias, Tomaszewski, Christian A., LaFree, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175722/ https://www.ncbi.nlm.nih.gov/pubmed/37188260 http://dx.doi.org/10.1002/emp2.12958 |
Ejemplares similares
-
Experience of the United Arab Emirates in the use of monoclonal antibody drug sotrovimab in high-risk vaccinated and unvaccinated patients with COVID-19: an observational cohort study
por: Abdalateef, Sumaya, et al.
Publicado: (2023) -
Experience Using Paxlovid for Patients With Coronavirus Disease 2019 in a Resource-Limited Emergency Department
por: Nene, Rahul V., et al.
Publicado: (2022) -
Sotrovimab Treatment for COVID-19 Effective in a B-Cell-Depleted Patient After Anti-CD20 Treatment
por: Murase, Kazuyuki, et al.
Publicado: (2023) -
Haemophilus influenzae Sepsis and Placental Abruption in an Unvaccinated Immigrant
por: Calner, Paul A, et al.
Publicado: (2012) -
The Effects of COVID-19 Surges on Otolaryngology Consults
por: Hughes, Evan B, et al.
Publicado: (2023)